The last 20 actions on file set price targets from $40.00 to $77.00, averaging $47.94.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 1 Oct 2026 | Wedbush | BUY | $47.00 |
| 1 Oct 2026 | Guggenheim | BUY | $47.00 |
| 1 Oct 2026 | H.C. Wainwright | BUY | $55.00 |
| 30 Sep 2026 | LifeSci Capital | BUY | $42.00 |
| 30 Sep 2026 | William Blair | BUY | – |
| 4 Sep 2026 | Clear Street | BUY | $48.00 |
| 3 Sep 2026 | LifeSci Capital | BUY | $42.00 |
| 3 Sep 2026 | Clear Street | BUY | $48.00 |
| 13 Aug 2026 | Stifel | BUY | $40.00 |
| 11 Aug 2026 | Jefferies | BUY | $48.00 |
| 11 Aug 2026 | H.C. Wainwright | BUY | $55.00 |
| 10 Aug 2026 | TD Cowen | BUY | – |
| 10 Aug 2026 | LifeSci Capital | BUY | $42.00 |
| 10 Aug 2026 | William Blair | BUY | – |
| 10 Aug 2026 | BTIG | BUY | $77.00 |
| 10 Aug 2026 | Guggenheim | BUY | $47.00 |
| 15 Jun 2026 | UBS | BUY | $45.00 |
| 14 Jun 2026 | UBS | BUY | $45.00 |
| 6 Jun 2026 | LifeSci Capital | BUY | $42.00 |
| 2 Jun 2026 | Wedbush | BUY | $45.00 |
No comments yet — be the first to weigh in on JBIO.